Sundar PichaiSundar Pichai earned $164M in 2023
H

Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P.

CEO of Halozyme Therapeutics

Education

M.B.Ch.B from the University of Glasgow

Field of Expertise

Healthcare & Life Sciences - Medicine

Born

January 1, 1962 - 63 years ago

Economy Sector

Healthcare

Current Tenure

11 years 0 months (Jan 2014 - Present)

Previous Experience

Executive Vice President and Chief Commercial Officer at Onyx Pharmaceuticals

Dr. Helen I. Torley is the CEO of Halozyme Therapeutics, Inc., bringing over 30 years of experience in the biotechnology and pharmaceutical industry. She earned her M.B.Ch.B. from the University of Glasgow. Before becoming CEO in 2014, she held significant...

Year

2022

Total Compensation

$6.62M

Salary

$920.00K

Board Justification

The compensation philosophy aligns executive compensation with the achievement of key strategic, financial, and operational goals, emphasizing long-term performance and stockholder value.

Bonus

$883.48K

Board Justification

The annual cash incentive earned for 2022 was based on the performance of the Company against pre-established corporate performance goals, achieving approximately 107% of her target annual cash incentive opportunity.

Other

$0.00

Board Justification

Restricted Stock

$4.81M(98.18K RSU)

Board Justification

The number of RSUs that vested in 2022, based on the vesting schedule of 25% annually over four years following the grant date, subject to continued employment.

Performance Metrics

The performance metrics for determining the CEO's compensation included revenue growth and adjusted EBITDA targets.